|
 |
European Pharmaceutical Contractor
|
The British biotech sector may be providing many globally-important technological answers, but it is also continuing to question how best to find and work with others in both discovery and development. No biotechnology company, however big, can completely go it alone. Getting together with US partners has often been the route for UK companies but as this article emphasises, there are wonderful opportunities in Europe and it is just as easy to cross the Channel as the Atlantic.
Whether their goal is technological, commercial, manufacturing or marketing know-how, partnerships are proving invaluable in the battle for biotech survival and added value. With an increasingly complex market, and with the time to achieve critical mass and gain entry to market continually shortening, I think it is inevitable that the search for appropriate alliances will continue to rise inexorably up the agenda. Despite its many strengths, this search is especially important for the UK biotech sector. While we in the UK are deservedly renowned for the innovative excellence of our basic ideas, it has also been known for others to get these ideas to market first and reap the rewards. Partnerships can help us to avoid this scenario.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Philip Oliver, International Technology Promoter, Life Sciences - Europe
The first International Technology Promoter with a specific European life sciences focus, Philip Oliver calls on his wide-ranging involvement with the biotechnology, pharmaceutical and related industries to promote partnerships with the UK. As a biotech business development specialist with 12 years' experience of working in the US and Europe, Philip has expertise in the areas of environment, health, safety, quality management, project management and toxicology.
Before joining Pera, Philip was European Manager of Business Development for a leading pharmaceutical and biotechnology research organisation. He has also held posts in the chemical and oil industry. Philip has a BSc with Associateship of the Royal College of Science from Imperial College, London and is involved with the biotech special interest group of the Drug Information Association.
|
|
|
|
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
Ultra slim and ultra quick
More info >>
|
|
 |
